A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study
Pharmacology, Toxicology and Pharmaceutical Science
6
7%
Nursing and Health Professions
3
4%
Biochemistry, Genetics and Molecular Biology
2
2%
Computer Science
2
2%
Other
10
12%
Unknown
41
49%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2024.
All research outputs
#876,299
of 32,932,292 outputs
Outputs from Diabetes Care
#1,132
of 12,900 outputs
Outputs of similar age
#14,649
of 363,423 outputs
Outputs of similar age from Diabetes Care
#30
of 97 outputs
Altmetric has tracked 32,932,292 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,900 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
